09:19 AM EDT, 05/07/2024 (MT Newswires) -- Dr. Reddy's Laboratories (RDY) reported fiscal Q4 earnings Tuesday of $0.94 per diluted share, up from $0.69 a year earlier.

A sole analyst polled by Capital IQ expected $0.62.

Revenue for the quarter ended March 31 was $850 million, up from $756 million a year earlier.

Analysts surveyed by Capital IQ expected $841 million.

Price: 74.33, Change: -0.55, Percent Change: -0.73